Lilly shares on track for worst day since 2021 after downbeat Zepbound sales forecast
Reuters was two-and-a-half minutes ahead of rivals on Eli Lilly’s unscheduled trading update, which showed fourth-quarter sales of its weight-loss […] The post Lilly shares on track for worst day since 2021 after downbeat Zepbound sales forecast appeared first on Reuters News Agency.
admin
0
47
Reuters was two-and-a-half minutes ahead of rivals on Eli Lilly’s unscheduled trading update, which showed fourth-quarter sales of its weight-loss drug Zepbound would miss Wall Street estimates. The drugmaker’s shares slumped 8% on the news.
The post Lilly shares on track for worst day since 2021 after downbeat Zepbound sales forecast appeared first on Reuters News Agency.
